David Lawrence
2011
In 2011, David Lawrence earned a total compensation of $1.1M as Chief of Business Operations and Former Chief Financial Officer at Acorda Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $91,158 |
|---|---|
| Option Awards | $458,627 |
| Salary | $281,283 |
| Stock Awards | $275,750 |
| Other | $7,350 |
| Total | $1,114,168 |
Lawrence received $458.6K in option awards, accounting for 41% of the total pay in 2011.
Lawrence also received $91.2K in non-equity incentive plan, $281.3K in salary, $275.8K in stock awards and $7.4K in other compensation.
Rankings
In 2011, David Lawrence's compensation ranked 5,269th out of 10,747 executives tracked by ExecPay. In other words, Lawrence earned more than 51.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,269 out of 10,747 | 51st |
Division Manufacturing | 1,912 out of 3,960 | 52nd |
Major group Chemicals And Allied Products | 415 out of 1,033 | 60th |
Industry group Drugs | 259 out of 781 | 67th |
Industry Biological Products, Except Diagnostic Substances | 42 out of 157 | 73rd |
Source: SEC filing on April 25, 2014.
Lawrence's colleagues
We found five more compensation records of executives who worked with David Lawrence at Acorda Therapeutics in 2011.
2011
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2011
Jane Wasman
Acorda Therapeutics
General Counsel
2011
Andrew Blight
Acorda Therapeutics
Chief Scientific Officer
2011
Thomas Wessel
Acorda Therapeutics
Chief Medical Officer
2011
Lauren Sabella
Acorda Therapeutics